164 related articles for article (PubMed ID: 4064042)
1. Carcinoembryonic antigen, ferritin, anionic glycoproteins, and their sialic acid content in advanced colorectal cancer.
Cunietti E; Locatelli E; Vaiani G; Gandini R; Gandini MC; Reggiani A; Monti M
Cancer Detect Prev; 1985; 8(1-2):227-32. PubMed ID: 4064042
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
Toumbis M; Chondros K; Ferderigos AS; Daganou M; Dema A; Dalamaga A; Kakari S; Stringou E
Anticancer Res; 1992; 12(4):1267-70. PubMed ID: 1503419
[TBL] [Abstract][Full Text] [Related]
3. Faecal carcinoembryonic antigen (CEA) in patients with large bowel cancer.
Stubbs RS; Nadkarni DM; Monsey HA
Eur J Surg Oncol; 1987 Oct; 13(5):433-6. PubMed ID: 3666160
[TBL] [Abstract][Full Text] [Related]
4. [Usefulness of biochemical tumor markers (CEA, Ca 19-9, ferritin and sialic acid) in diagnosis and prognosis of colonic neoplasms].
Krasnodebski IW
Wiad Lek; 1998; 51(3-4):132-41. PubMed ID: 9658987
[TBL] [Abstract][Full Text] [Related]
5. [Association of ferritin with the CEA test in post-operative monitoring of colo-rectal, breast and stomach carcinomas].
Fanciullacci A; Cappetti P; Ciaccio B; Caponi A; Bartoli P; Taviani R; Berti P
Quad Sclavo Diagn; 1984 Dec; 20(4):355-63. PubMed ID: 6537546
[TBL] [Abstract][Full Text] [Related]
6. Combined measurement and significance of lipid-bound sialic acid and carcinoembryonic antigen in detection of human cancer.
Munjal DD; Picken J; Pritchard J
Diagn Immunol; 1984; 2(1):36-43. PubMed ID: 6499373
[TBL] [Abstract][Full Text] [Related]
7. Immunostaining of colorectal cancer with monoclonal anti-CEA antibodies compared to serum and tumor CEA content.
Pagé M; Dalifard I; Bertrand G; Bocquillon PG; Daver A
Anticancer Res; 1986; 6(5):893-6. PubMed ID: 3541780
[TBL] [Abstract][Full Text] [Related]
8. The biological and clinical significance of tumor markers in tissue extracts.
Castelli M; Sega FM; Sciarretta F; Casale V; Coloni F; Sega E
Cancer Detect Prev; 1983; 6(1-2):61-6. PubMed ID: 6883394
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of serum immunosuppressive substance as a marker of colorectal cancer].
Matsumoto K
Nihon Geka Gakkai Zasshi; 1988 Feb; 89(2):192-9. PubMed ID: 3362126
[TBL] [Abstract][Full Text] [Related]
10. Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.
Chester KA; Begent RH
Clin Exp Immunol; 1984 Dec; 58(3):685-93. PubMed ID: 6509799
[TBL] [Abstract][Full Text] [Related]
11. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
Dabrowska B; Krasnodebski IW; Tadeusiak W
Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):890-1. PubMed ID: 1669462
[TBL] [Abstract][Full Text] [Related]
12. [Significance of CEA and CA242 in the diagnosis of colorectal carcinoma].
Wu J; Yu H; Shao Y
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):438-40. PubMed ID: 8697997
[TBL] [Abstract][Full Text] [Related]
13. The radioimmunoassay of a carcinoembryonic antigen fraction.
Fong S; Betancourt M; Costa H; Moroz S
Neoplasma; 1982; 29(1):9-18. PubMed ID: 6175914
[TBL] [Abstract][Full Text] [Related]
14. CEA and ferritin in chronic pancreatic disease: a comparative evaluation.
Fabris C; Farini R; Piccoli A; Del Favero G; Panucci A; Plebani M; Pedrazzoli S; Nitti D; Naccarato R
Hepatogastroenterology; 1985 Jun; 32(3):146-8. PubMed ID: 4018709
[TBL] [Abstract][Full Text] [Related]
15. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
16. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
[TBL] [Abstract][Full Text] [Related]
17. Preoiperative carcinoembryonic antigen level and prognosis in colorectal cancer.
Chapuis PH; Newland RC; Payne JE; Macpherson JG; Pheils MT
Med J Aust; 1980 Aug; 2(3):140-3. PubMed ID: 7421682
[TBL] [Abstract][Full Text] [Related]
18. [Significance of CEA in gastric and colorectal cancer].
Uehara K; Miyamoto Y; Izuo M; Shiozaki H; Aiba S; Matsumoto H
Nihon Geka Gakkai Zasshi; 1985 Apr; 86(4):435-42. PubMed ID: 3889583
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer.
Gebauer G; Müller-Ruchholtz W
Cancer Detect Prev; 2001; 25(4):344-51. PubMed ID: 11531011
[TBL] [Abstract][Full Text] [Related]
20. Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer.
Gail MH; Muenz L; McIntire KR; Radovich B; Braunstein G; Brown PR; Deftos L; Dnistrian A; Dunsmore M; Elashoff R
J Natl Cancer Inst; 1986 May; 76(5):805-16. PubMed ID: 2422426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
